PDCD1 and cancer: All three lymphocyte cell types showed enrichment in pathways strongly involved in immune cell response to cancer, like PD-L1/PD-1 checkpoint, ErbB, MAPK, TNF, PI3K/Akt/mTOR, EGFR, VEGF, NF-kappa B signaling.